Abstract
Background Minimizing delays in disease identification and reporting improves the timeliness of surveillance data, and can reduce transmission of COVID-19. Our study investigates factors associated with timely testing and reporting of COVID-19 during the first pandemic wave in one province of Canada.
Methods We identified all persons with confirmed SARS-CoV-2 infection residing in private households across the largest province of Canada, Ontario from the date of the first confirmed case in Ontario (January 25) to July 19, 2020. Our primary outcomes consisted of: (1) specimen collection within 1 day of symptom onset (test seeking), (2) test result reported to local public health within 1 day of specimen collection (test turnaround), and (3) entry of case data into the provincial database within 1 day of reporting test results (reporting). We examined 14 covariates including eight case characteristics, and six neighborhood characteristics. In addition to descriptive measures, logistic regression models were fitted. Unadjusted models included the covariate alone, while adjusted models included age, gender, month, and region.
Findings Among 27,198 COVID-19 cases from January 25 2020 to July 19 2020, 28·7% had timely test seeking, 40·2% had timely test turnaround, and 75·5% had timely reporting. Male gender had lower odds of timely test seeking (adjusted odds ratio [aOR] 0·79 [95% CI: 0·74-0·85]) compared to females. Healthcare worker status (aOR 2·77 [95% CI: 2·52-3·05] compared to non-healthcare workers), and age ≥80 years (aOR 1·59 [95% CI: 1·33-1·91] compared to 40-59 year olds) were associated with timely test seeking. Specimen collection on Fridays and Saturdays (aOR 0·88 [95% CI: 0·79-0·98], aOR 0·83 [95% CI: 0·74-0·92] respectively, compared to Wednesdays) had lower odds of timely test turnaround. Urban areas (aOR 1·55 [95% CI: 1·41-1·70] compared to rural areas) were associated with timely test turnaround. Urban areas (aOR 0·79 [95% CI: 0·70-0·89] compared to rural areas) were less likely to have timely reporting.
Interpretation Individual, neighborhood, and administrative factors are associated with timely testing and reporting of SARS-CoV-2 infections. These findings present considerations for developing targeted strategies to minimize delays and improve timely testing and reporting of SARS-CoV-2 infections.
Funding This study was funded by Public Health Ontario.
Evidence before this study We searched PubMed and medRxiv up to November 30 2020 to identify studies examining the impact of delays in the disease reporting process on the public health response to COVID-19. We used the search terms (“2019-nCoV” OR “COVID-19” OR “SARS-CoV-2”) AND (“delays” OR “timely” OR “reporting” OR “test” OR “turnaround”), and reviewed reference lists of any relevant articles in the original search. Numerous modeling studies have highlighted the importance of timely testing and reporting to effectively control the spread of COVID-19. Additional studies have also identified delays of only 1 day in testing were associated with increased risk of secondary transmission within households. However no study has described the multiple delays in the disease reporting process of COVID-19 and examined factors associated with timely disease reporting using a large population cohort.
Added value of this study Our study described timely test seeking, test turnaround, and reporting for laboratory-confirmed COVID-19 cases in Ontario, Canada and identified associated individual, neighbourhood, and administrative factors. To the best of our knowledge, this study is the first to describe detailed delays in the disease reporting process of COVID-19 and identified associated factors using a large population cohort.
Implications of all the available evidence Numerous individual, neighborhood, and administrative characteristics are associated with timely testing and reporting of COVID-19. These identified factors may be used to develop strategies such as broadened test access, prioritization of vulnerable populations, and increased testing capacity to reduce delays in testing and reporting and improve the effectiveness of public health response to COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Public Health Ontario.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We obtained ethics approval from Public Health Ontario's Research Ethics Board.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data sharing requests should be directed to Public Health Ontario.
